EAM Investors’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-69,241
| Closed | -$2.24M | – | 295 |
|
|
2024
Q1 | $2.24M | Sell |
69,241
-41,688
| -38% | -$1.35M | 0.35% | 136 |
|
|
2023
Q4 | $4.67M | Buy |
110,929
+8,409
| +8% | +$354K | 0.83% | 14 |
|
|
2023
Q3 | $3.93M | Buy |
102,520
+62,724
| +158% | +$2.41M | 0.76% | 11 |
|
|
2023
Q2 | $755K | Buy |
+39,796
| New | +$755K | 0.14% | 251 |
|
|
2021
Q1 | – | Sell |
-32,498
| Closed | -$1.5M | – | 389 |
|
|
2020
Q4 | $1.5M | Sell |
32,498
-2,895
| -8% | -$134K | 0.25% | 190 |
|
|
2020
Q3 | $1.25M | Buy |
+35,393
| New | +$1.25M | 0.3% | 153 |
|